The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
Psychoneuroendocrinology January 2015 Rakesh Jetly, Alexandra Heber, George Fraser et al.
Investigate the efficacy of nabilone capsules (NAB) in reducing the frequency and intensity of nightmares in subjects with PTSD. Canadian male military personnel with PTSD, who despite standard treatment continued to experience trauma-related nightmares, received double-blind treatment with 0.5mg NAB or placebo (PBO), and then titrated to the effective dose (nightmare suppression) or reaching a...
DOI: 10.1016/j.psyneuen.2014.11.002 (opens in new tab)
Full text (opens in new tab)
PTSD
Nabilone
Nightmares
Rct
+1